5/4/2022

Dorzolamide Ophthalmic Solution

Products Affected - Description

- Trusopt ophthalmic solution, Merck, 2%, 10 mL Ocumeter Plus bottle, 1 count, NDC 00006-3519-36 - discontinued
- Dorzolamide ophthalmic solution, Teva, 2%, 10 mL bottle, 1 count, NDC 00591-2481-79 - discontinued
- Dorzolamide ophthalmic solution, Teva, 2%, 10 mL bottle, 1 count, NDC 00093-7618-43 - discontinued

Reason for the Shortage

- Akorn has dorzolamide ophthalmic solution available.
- Merck discontinued Trusopt.
- Sandoz has dorzolamide ophthalmic solution available
- Teva discontinued dorzolamide ophthalmic solution in April 2018.
- Bausch Health has dorzolamide ophthalmic solution available.

Available Products

- Dorzolamide ophthalmic solution, Akorn, 2%, 10 mL bottle, 1 count, NDC 50383-0232-10
- Dorzolamide ophthalmic solution, Bausch Health, 2%, 10 mL bottle, 1 count, NDC 24208-0485-10
- Dorzolamide ophthalmic solution, Sandoz, 2%, 10 mL bottle, 1 count, NDC 61314-0019-10

Updated

Updated May 4, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created October 30, 2017 by Benjamin Witt, PharmD, BCPS, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.